Article info
PDFTherapeutics
Randomised controlled trial
Intensive glucose lowering (HbA1c target<6.0%) for people with type 2 diabetes increases mortality
- Correspondence to Jonathan E Shaw
Baker IDI Heart and Diabetes Institute, Department of Clinical Diabetes and Epidemiology, Level 4 99 Commercial Road Melbourne VIC 3004, Australia; jonathan.shaw{at}bakeridi.edu.au
Citation
Intensive glucose lowering (HbA1c target<6.0%) for people with type 2 diabetes increases mortality
Publication history
- First published November 20, 2011.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions